<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To obtain a clearer definition of the influence of <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">cardiac disease</z:e> on the development of cerebrovascular disease (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>), we carried out a comparative study of two groups of patients, matched for age and sex, one with and one without <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>These were compared with regard to the incidence of <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">cardiac disease</z:e>, <z:hpo ids='HP_0000822'>hypertension</z:hpo> and <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>On comparing the groups as a whole a significant preponderance of <z:hpo ids='HP_0000822'>hypertension</z:hpo> is shown in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>, but no significant difference in the frequency of <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">cardiac disease</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>With regard to the site of the lesion in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> there is a clear preponderance of <z:hpo ids='HP_0011675'>cardiac arrhythmias</z:hpo> when the territory of the carotid artery is affected </plain></SENT>
<SENT sid="4" pm="."><plain>This seems to favour an embolic, rather than a haemodynamic mechanism in the aetiology of cardiogenic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Hence, it follows for therapeutic purposes that in the case of <z:hpo ids='HP_0011675'>arrhythmias</z:hpo>, prophylaxis with aggregation-inhibiting drugs to prevent recurrence of embolism and adequate treatment of <z:hpo ids='HP_0000822'>hypertension</z:hpo> are useful measures, whereas administration of digitalis should be determined only by the presence of <z:hpo ids='HP_0001635'>cardiac insufficiency</z:hpo> </plain></SENT>
</text></document>